Global Skin Substitutes 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR072507350

Publication Date:

July 11, 2025

Pages:

113

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Skin Substitutes market size was valued at US$ 1683 million in 2023 and is forecast to a readjusted size of USD 4703 million by 2030 with a CAGR of 16.4% during review period.
Skin substitutes are bio-matrices that fulfil the functions of the cutaneous dermal layer: control of pain and scarring. They act as matrices or scaffolds and promote new tissue growth and enhance wound healing, with enhanced pliability and a more favourable scar.
As the technology of skin substitutes is not relatively mature, the downstream market, especially for Chronic Wounds market is growing fast, there are a lot of enterprises in the skin substitutes market. The skin substitutes market competition will be still intense. Integra LifeSciences, Smith & Nephew, Organogenesis, Allergan and MiMedx is the leading manufacturer in the Skin Substitutes market. The top 5 listed companies accounted for 60% of the market share in terms of revenue.
麻豆原创 development trends and prospects
Technological innovation:
With the continuous development of materials science, biotechnology and intelligent manufacturing, skin substitutes will become more intelligent, personalized and customized.
The continuous emergence of new biomaterials, synthetic materials and biocomposites will inject new vitality into the market.
麻豆原创 expansion:
In addition to traditional medical and beauty fields, skin substitutes will also expand to consumer electronics, robotics and other fields.
The further development of the international market and the improvement of brand influence will promote the increase in the export volume of Chinese skin products.
Policy support:
The government's continuous strengthening of supervision of the medical device industry and the improvement of supervision of emerging formats such as medical beauty will provide strong guarantees for the healthy development of the market.
The support and promotion of industrial policies will promote the rapid development of the skin substitute industry.
This report is a detailed and comprehensive analysis for global Skin Substitutes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Skin Substitutes market size and forecasts, in consumption value ($ Million), 2019-2030
Global Skin Substitutes market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Skin Substitutes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Skin Substitutes market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Skin Substitutes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Skin Substitutes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Integra LifeSciences, Gunze Medical, Medskin Suwelack, 础苍颈办补听罢丑别谤补辫别耻迟颈肠蝉, Symatese Group, Smith & Nephew, Allergan, Tissue Regenix, Organogenesis, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Skin Substitutes market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Acellular
Cellular Allogeneic
Cellular Autologus
Others
麻豆原创 segment by Application
Burn
Diabetic Ulcers/Vascular Ulcers
Others
麻豆原创 segment by players, this report covers
Integra LifeSciences
Gunze Medical
Medskin Suwelack
础苍颈办补听罢丑别谤补辫别耻迟颈肠蝉
Symatese Group
Smith & Nephew
Allergan
Tissue Regenix
Organogenesis
Mylan
Medtronic
MiMedx
Mallinckrodt
Unitrump Bio
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Skin Substitutes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Skin Substitutes, with revenue, gross margin, and global market share of Skin Substitutes from 2019 to 2024.
Chapter 3, the Skin Substitutes competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Skin Substitutes market forecast, by regions, by Type and by Application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Skin Substitutes.
Chapter 13, to describe Skin Substitutes research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Skin Substitutes by Type
1.3.1 Overview: Global Skin Substitutes 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Skin Substitutes Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Acellular
1.3.4 Cellular Allogeneic
1.3.5 Cellular Autologus
1.3.6 Others
1.4 Global Skin Substitutes 麻豆原创 by Application
1.4.1 Overview: Global Skin Substitutes 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Burn
1.4.3 Diabetic Ulcers/Vascular Ulcers
1.4.4 Others
1.5 Global Skin Substitutes 麻豆原创 Size & Forecast
1.6 Global Skin Substitutes 麻豆原创 Size and Forecast by Region
1.6.1 Global Skin Substitutes 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Skin Substitutes 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Skin Substitutes 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Skin Substitutes 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Skin Substitutes 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Skin Substitutes 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Skin Substitutes 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Integra LifeSciences
2.1.1 Integra LifeSciences Details
2.1.2 Integra LifeSciences Major Business
2.1.3 Integra LifeSciences Skin Substitutes Product and Solutions
2.1.4 Integra LifeSciences Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Integra LifeSciences Recent Developments and Future Plans
2.2 Gunze Medical
2.2.1 Gunze Medical Details
2.2.2 Gunze Medical Major Business
2.2.3 Gunze Medical Skin Substitutes Product and Solutions
2.2.4 Gunze Medical Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Gunze Medical Recent Developments and Future Plans
2.3 Medskin Suwelack
2.3.1 Medskin Suwelack Details
2.3.2 Medskin Suwelack Major Business
2.3.3 Medskin Suwelack Skin Substitutes Product and Solutions
2.3.4 Medskin Suwelack Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Medskin Suwelack Recent Developments and Future Plans
2.4 础苍颈办补听罢丑别谤补辫别耻迟颈肠蝉
2.4.1 础苍颈办补听罢丑别谤补辫别耻迟颈肠蝉 Details
2.4.2 础苍颈办补听罢丑别谤补辫别耻迟颈肠蝉 Major Business
2.4.3 础苍颈办补听罢丑别谤补辫别耻迟颈肠蝉 Skin Substitutes Product and Solutions
2.4.4 础苍颈办补听罢丑别谤补辫别耻迟颈肠蝉 Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 础苍颈办补听罢丑别谤补辫别耻迟颈肠蝉 Recent Developments and Future Plans
2.5 Symatese Group
2.5.1 Symatese Group Details
2.5.2 Symatese Group Major Business
2.5.3 Symatese Group Skin Substitutes Product and Solutions
2.5.4 Symatese Group Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Symatese Group Recent Developments and Future Plans
2.6 Smith & Nephew
2.6.1 Smith & Nephew Details
2.6.2 Smith & Nephew Major Business
2.6.3 Smith & Nephew Skin Substitutes Product and Solutions
2.6.4 Smith & Nephew Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Smith & Nephew Recent Developments and Future Plans
2.7 Allergan
2.7.1 Allergan Details
2.7.2 Allergan Major Business
2.7.3 Allergan Skin Substitutes Product and Solutions
2.7.4 Allergan Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Allergan Recent Developments and Future Plans
2.8 Tissue Regenix
2.8.1 Tissue Regenix Details
2.8.2 Tissue Regenix Major Business
2.8.3 Tissue Regenix Skin Substitutes Product and Solutions
2.8.4 Tissue Regenix Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Tissue Regenix Recent Developments and Future Plans
2.9 Organogenesis
2.9.1 Organogenesis Details
2.9.2 Organogenesis Major Business
2.9.3 Organogenesis Skin Substitutes Product and Solutions
2.9.4 Organogenesis Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Organogenesis Recent Developments and Future Plans
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Skin Substitutes Product and Solutions
2.10.4 Mylan Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Mylan Recent Developments and Future Plans
2.11 Medtronic
2.11.1 Medtronic Details
2.11.2 Medtronic Major Business
2.11.3 Medtronic Skin Substitutes Product and Solutions
2.11.4 Medtronic Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Medtronic Recent Developments and Future Plans
2.12 MiMedx
2.12.1 MiMedx Details
2.12.2 MiMedx Major Business
2.12.3 MiMedx Skin Substitutes Product and Solutions
2.12.4 MiMedx Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 MiMedx Recent Developments and Future Plans
2.13 Mallinckrodt
2.13.1 Mallinckrodt Details
2.13.2 Mallinckrodt Major Business
2.13.3 Mallinckrodt Skin Substitutes Product and Solutions
2.13.4 Mallinckrodt Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Mallinckrodt Recent Developments and Future Plans
2.14 Unitrump Bio
2.14.1 Unitrump Bio Details
2.14.2 Unitrump Bio Major Business
2.14.3 Unitrump Bio Skin Substitutes Product and Solutions
2.14.4 Unitrump Bio Skin Substitutes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Unitrump Bio Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Skin Substitutes Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Skin Substitutes by Company Revenue
3.2.2 Top 3 Skin Substitutes Players 麻豆原创 Share in 2023
3.2.3 Top 6 Skin Substitutes Players 麻豆原创 Share in 2023
3.3 Skin Substitutes 麻豆原创: Overall Company Footprint Analysis
3.3.1 Skin Substitutes 麻豆原创: Region Footprint
3.3.2 Skin Substitutes 麻豆原创: Company Product Type Footprint
3.3.3 Skin Substitutes 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Skin Substitutes Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Skin Substitutes 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Skin Substitutes Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Skin Substitutes 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Skin Substitutes Consumption Value by Type (2019-2030)
6.2 North America Skin Substitutes 麻豆原创 Size by Application (2019-2030)
6.3 North America Skin Substitutes 麻豆原创 Size by Country
6.3.1 North America Skin Substitutes Consumption Value by Country (2019-2030)
6.3.2 United States Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Skin Substitutes Consumption Value by Type (2019-2030)
7.2 Europe Skin Substitutes Consumption Value by Application (2019-2030)
7.3 Europe Skin Substitutes 麻豆原创 Size by Country
7.3.1 Europe Skin Substitutes Consumption Value by Country (2019-2030)
7.3.2 Germany Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Skin Substitutes Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Skin Substitutes Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Skin Substitutes 麻豆原创 Size by Region
8.3.1 Asia-Pacific Skin Substitutes Consumption Value by Region (2019-2030)
8.3.2 China Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Skin Substitutes Consumption Value by Type (2019-2030)
9.2 South America Skin Substitutes Consumption Value by Application (2019-2030)
9.3 South America Skin Substitutes 麻豆原创 Size by Country
9.3.1 South America Skin Substitutes Consumption Value by Country (2019-2030)
9.3.2 Brazil Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Skin Substitutes Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Skin Substitutes Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Skin Substitutes 麻豆原创 Size by Country
10.3.1 Middle East & Africa Skin Substitutes Consumption Value by Country (2019-2030)
10.3.2 Turkey Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Skin Substitutes 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Skin Substitutes 麻豆原创 Drivers
11.2 Skin Substitutes 麻豆原创 Restraints
11.3 Skin Substitutes Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Skin Substitutes Industry Chain
12.2 Skin Substitutes Upstream Analysis
12.3 Skin Substitutes Midstream Analysis
12.4 Skin Substitutes Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Integra LifeSciences
Gunze Medical
Medskin Suwelack
础苍颈办补听罢丑别谤补辫别耻迟颈肠蝉
Symatese Group
Smith & Nephew
Allergan
Tissue Regenix
Organogenesis
Mylan
Medtronic
MiMedx
Mallinckrodt
Unitrump Bio

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.